Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders.

The company came out with a public issue in Nov.'94 and broadened its footprint its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point.

The company broadened its footprint operations into into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India.

The company has created and deployed a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also created and deployed a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.